5-Methylurapidil
Clinically, some vasodilating drugs such as papaverine and prostaglandin El, and also phentolamine, a non selective a-adrenoceptor antagonist, have been used for the treatment of impotence (1). Phentolamine antago nizes adrenaline-, noradrenaline and phenylephrine induced contractions of corpus cavernosum penis (CCP) (2). Prazosin, a selective a,-adrenoceptor antagonist, also attenuates the noradrenaline and electrical field stimulation-induced contractions of human and rabbit CCP (3); and a new selective aiA-adrenoceptor antago nist, tamsulosin (R-(-)-YM12617), exerts a more potent antagonistic activity than prazosin (4). These results indicate that contractions to catecholamines in the CCP are mediated via the a,-adrenoceptor subtype.
Recently, a,-adrenoceptors have been classified into three receptor subtypes. Morrow and Creese (5) reported that a1-adrenoceptors can be defined as a1A with a high affinity for WB4101 and aIB with low affinity for WB4101. Chloroethylclonidine inactivates the subtype with a low affinity for WB4101 (a1B) (6). Molecular biological studies have also identified a,-adrenoceptor subtypes, with three receptors being cloned and termed ala (formerly known as aic), alb and aid (formerly also known as ala or ala/d) (7-9). It appears that the pharmacological properties of the cloned alb-receptor are identical to those of the native alB-adrenoceptor. It has been suggested that the cloned ala (aic)-receptor represents the native alA-adrenoceptor (10-12), and the receptor in rat aorta represents a functional aID-adrenoceptor (13). Both aiA and aiB adrenoceptor subtypes seem to be present in porcine CCP smooth muscle, and the aiA-adrenoceptor may be the predominant subtype (14) . mRNAs for all three cloned receptor subtypes (alb, air, aid) of a,-adrenoceptor have been identified in human CCP tissues using in situ hybridization, and the aic and ald-adrenoceptor subtypes seem to be predominant (15). subtype mediating the responses of the rabbit CCP by comparing the effects of selective alA-adrenoceptor antagonists (WB4101, 5-methylurapidil, tamsulosin), a partial al-adrenoceptor agonist with alA-adrenoceptor antagonistic activity (oxymetazoline) (16) and a relatively selective alB-adrenoceptor antagonist (chloroethylcloni dine) on the concentration-response curves to phenyl ephrine.
MATERIALS AND METHODS

Tension recordings
Male New Zealand White rabbits (3.0-3.5 kg; Charles Rivers, Margate, UK) were killed by an overdose of so dium pentobarbital and exsanguinated. The penis was sur gically removed, and the urethra and connective tissues were excised. Two preparations of the CCP were careful ly dissected free from the tunica albuginea, and then each cut into three pieces (1.5 x 2 x 6 mm). The tissues were mounted in 5-ml organ baths filled with Krebs-bicarbon ate solution of the following composition: 118.4 mM NaCI, 4.7 mM KCI, 1.9 mM CaC12, 25.0 mM NaHCO3, 1.2 mM MgSO4i 1.2 mM KH2PO4 and 11.7 mM glucose, at 37V and oxygenated with 95010 02 and 5010 CO2. Tis sues were set up under 2-g resting tension and the tensions developed following the addition of phenylephrine were measured by means of isometric force transducers (UF1, 57 g sensitivity; Lectromed Ltd., Herts, UK) connected to a PCA-sl computer (Tandon plc, Reddich, UK) through an analogue to digital converter (Cambridge Electronic Design Ltd., Cambridge, UK). Developed tension was recorded using "CHART" and analyzed using "SPIKE 2" software (Cambridge Electronic Design Ltd.). tagonists, and these were used to correct for time-depend ent changes in tissue sensitivity during the experiment. All concentration-response curves were obtained in the presence of cocaine (10 rM) and corticosterone (10 1M) to inhibit amine uptake and also propranolol (1 eM) to antagonize 13-adrenoceptors. As a measure of antagonist affinity, Schild plots were constructed and pA2 values determined from the intercept on the abscissa (17). If maximum responses were not al tered by antagonists and the slopes of Schild plots were similar to unity, pKB values (-logarithm dissociation constant) were determined from the equation:
where CR is the concentration-ratio (ratio of the EC50 values in the absence and presence of the antagonist) obtained with a concentration [B] 
RESULTS
Control experiments
Phenylephrine (1 mM) caused a long-lasting contrac tion, and the phenylephrine-induced contraction was concentration-dependent ( Fig. 1) . Repeating concen tration-response curves to phenylephrine did not result in any significant change in either EC50 values or maximum responses (Fig. 2) . In control experiments (n=7), the geometric mean EC50 value for the first concentration response curve [7.4 (95% confidence limits = 4.4 12.6) pM] to phenylephrine was almost identical to those of subsequent curves, the EC50 value being 10.3 (6.4-16.6) ,uM for the fourth control concentration-response curve. Similarly, the maximum responses were also unchanged (first curve =3.64±0.83 g, fourth curve =4.00±0.58 g). Competitive antagonists WB4101 (30 300 nM), 5-methylurapidil (0.1-1 pM) and tamsulosin (1-10 nM) behaved as competitive an tagonists, shifting the concentration-response curve to phenylephrine to the right without altering maximum responses (Fig. 3, Table 1 ). Schild plots for all three an tagonists (Fig. 4) had slopes not significant from unity ( Non-competitive antagonists Oxymetazoline (1 pM) caused a small contraction that returned to resting tension within 30 min and then behaved as an antagonist of phenylephrine-induced contractions. Oxymetazoline shifted the concentration response curve to phenylephrine to the right but also reduced the maximum response (Fig. 5A, Table 1 ). The apparent pKB value calculated using this one concentra tion of antagonist was 6.99.
Chloroethylclonidine also produced significant right ward shifts of the concentration-response curves to phenylephrine, causing 6 and 32-fold shifts at 25 and 100 uM, respectively (Fig. 5B) . Maximum responses to phenylephrine were not significantly affected by chloro ethylclonidine (Table 1) . 
DISCUSSION
At the a,-adrenoceptors of the rabbit CCP, WB4101, 5-methylurapidil and tamsulosin acted as competitive an tagonists with a high affinity for the receptor. The affinity value (pKB) of 8.05 for WB4101, however, is significantly lower than those reported at the alA-adrenoceptors of rat vas deferens (9.01-9.58) (18-22) and human vas defe rens (9.2) (16), but is similar to those obtained for the alB-adrenoceptors of the rat spleen (8.4) (19) and guinea pig aorta (8.4; R. Chess-Williams et al., unpublished data), using identical experimental conditions. Similar results are obtained for the radioligand binding studies of 5-methylurapidil; and the values obtained for the a,B adrenoceptors of the rat liver and spleen (pKi = 7.56 7.63) (10, 18, 23, 24) are similar to the affin ity of 5-methylurapidil in the rabbit CCP (pKB=7.59).
Affinity values (pKB) for 5-methylurapidil at functional alA-adrenoceptors are significantly higher (8.43-9.10) (18, (20) (21) (22) than that obtained from rabbit CCP. There fore, the results of WB4101 and 5-methylurapidil suggest that there may be a functionally predominant a,B adrenoceptor population present in the rabbit CCP.
Tamsulosin is an a,-adrenoceptor antagonist that dis tinguishes between al-adrenoceptor subtypes, being selec tive for the a,a adrenoceptor subtype (pKi=10.64) over the alb subtype (pKi=9.06) in the radioligand binding study on the cloned receptor (25). The affinity of tam sulosin for the al-adrenoceptor of the rabbit CCP (pKB =9 .21) is similar to the value for the alb-adrenoceptor in the radioligand binding study on the cloned receptor and is similar to the value of 9.0 (pKB) obtained for the func tional a,B-adrenoceptors of the rat spleen (26). In func tional studies, tamsulosin has been shown to exert non competitive effects at the alA-adrenoceptors of the rat and human vas deferens (27), reducing maximum responses to phenylephrine and producing Schild plots with slopes greater than unity. No such non-competitive effects were observed on the rabbit CCP. The results of tamsulosin in the rabbit CCP also support the suggestion of a func tionally predominant a,B-adrenoceptor population in the rabbit CCP.
Oxymetazoline caused a small contraction and acted as an antagonist of phenylephrine-induced contractions in the rabbit CCP. Oxymetazoline acts as a partial agonist at a,-adrenoceptors with low relative efficacy as compared to noradrenaline (28) and does not cause any agonistic effect in guinea pig spleen (21). In human vas deferens, oxymetazoline does not cause any agonistic effect and acts as an antagonist of phenylephrine-induced contraction (16). Therefore, oxymetazoline may have partial agonistic activity followed by an antagonistic one in rabbit CCP. The affinity of oxymetazoline in rabbit CCP (apparent pKB=6.99) is lower than those reported for the alA adrenoceptors in radioligand binding studies in rat sali vary gland (pKi = 8.06, 8.49 ) and similar to those values reported for a,B-adrenoceptors in rat liver (pKi=6.63, 6.68) (10, 29) . From the data using competitive an tagonists and oxymetazoline, it appears that the responses to phenylephrine in rabbit CCP are mediated predomi nantly via a population of a,B-adrenoceptors, and this conclusion is supported in experiments performed with chloroethylclonidine. Chloroethylclonidine caused a parallel shift without altering the maximum response in rabbit CCP. Early studies with chloroethylclonidine suggested that this com pound was an irreversible antagonist that selectively inac tivated the a,B but not the alA-adrenoceptor subtype (6). Recent studies, however, have demonstrated the ability of chloroethylclonidine to inactivate all the a,-adrenoceptor subtypes to some extent (30). The alb and ald-adreno ceptor subtypes appear to be equally sensitive to chloro ethylclonidine, whilst higher concentrations or longer incubation periods are required to inactivate the ala subtype. We have previously shown that the same con centration (25 p M) of chloroethylclonidine results in an antagonism of functional alB but not alA-adrenoceptor mediated responses (19). The effect observed with chloro ethylclonidine is, therefore, indicative of the presence of either an a1B or alD-adrenoceptor in rabbit CCP, but the presence of an a1D-adrenoceptor in rabbit CCP can be ruled out by the low affinity values obtained for WB4101 and tamsulosin. The pKB values of 8.05 and 9.21 obtained for WB4101 and tamsulosin in the present study are simi lar to the values of 8.43 and 9.06 obtained for the cloned alb-adrenoceptor, but they are significantly lower than the values of 9.37 and 10.06 reported for the cloned aid adrenoceptor (10, 25). The apparent pKB value (6.99) ob tained for oxymetazoline also supports the conclusion that responses in the rabbit CCP are mediated via an a1B adrenoceptor, since the cloned ald-adrenoceptor has a tenfold lower affinity for this drug (pKB=6.02) (10). The data obtained with the competitive antagonists and oxymetazoline can, therefore, only be explained by the presence of a functional a1B-adrenoceptor in this tissue.
On the rabbit CCP, chloroethylclonidine produced a significant rightward shift of the concentration-response curves to phenylephrine without the reduction of maxi mum responses. Chloroethylclonidine reduces the maxi mum responses to noradrenaline in the rat spleen (20, 31) , in which the a1-adrenoceptor subtype is functionally the a1B-subtype. Therefore, the competitive antagonism of chloroethylclonidine to the phenylephrine-induced con traction suggests that a significant receptor reserve may exist in the rabbit CCP when using phenylephrine.
While the present study shows the a1B-adrenoceptor subtype to predominate in the rabbit CCP, the fact that a1A-adrenoceptor seems to be the predominant receptor subtype in porcine corpus cavernosum smooth muscle (14) demonstrates that there are species differences in predominance of a1-adrenoceptor subtypes. In humans, mRNA levels suggest that the al, and ald-adrenoceptor subtypes are predominantly expressed in corpus caverno sum smooth muscle (15), but studies identifying the pharmacological characteristics of the functional receptor have yet to be performed. Muramatsu et al. (1990) proposed another subclas sification of a1-adrenoceptor subtypes (a1H: high sensi tive, a1L: low sensitive, aIN: neither a1H nor a1L) based on the sensitivity to prazosin (32). It is difficult to directly discuss the alH-, a1L and a1N-adrenoceptor subtypes in rabbit CCP from the viewpoint of prazosin which we did not use in this study. However, the alH-adrenoceptor is sensitive, and the a1L or a1N-adrenoceptor is insensitive to chloroethylclonidine (32), whereas the a1-adrenoceptor subtype in rabbit CCP was sensitive to chloroethylcloni dine. Furthermore, a1-adrenoceptors can be subdivided into five subtypes (alA, a1B, a1D, alL, a1N) ; and the alA-, a1B and a1D-adrenoceptor subtypes are categorized into the a1H group (33). Consequently, it is suggested that the a1-adrenoceptor in rabbit CCP belongs to the a1H-sub type consisting of alA-, a1B and a1D-adrenoceptors. 141-149 (1994) 
